Login / Signup

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

Meletios- Athanasios DimopoulosPhillipe MoreauBradley AugustsonNelson CastroTomas PikaSosana DelimpasiJavier De la RubiaAngelo MaiolinoTony ReimanJoaquin Martinez-LopezThomas MartinJoseph R MikhaelKwee YongMarie-Laure RisseGaelle AssetSylvia MarionRoman Hajek
Published in: American journal of hematology (2022)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • low dose
  • acute myeloid leukemia
  • high dose
  • randomized controlled trial
  • diffuse large b cell lymphoma
  • clinical trial
  • combination therapy
  • replacement therapy